Hyperspectral Imaging Patent Landscape 2026
Hyperspectral Imaging Patent Landscape in 2026
Hyperspectral imaging is a maturing field with 7,707 patent families in scope, led by medtech and defense incumbents holding a moderate concentration advantage. The United States is the dominant filing jurisdiction, and activity has plateaued near its 2020 peak, signaling a shift from rapid expansion toward consolidation and adjacent-application development.
Cilag leads a moderately concentrated field with a clear medtech and sensing core
Cilag GmbH International holds the top position with 293 patent families, followed by Ventana Medical Systems with 191 and IMEC with 146, establishing a three-tier structure where the medical-imaging and photonics incumbents dominate the upper ranks.
The top five filers account for 19% of the combined output of the hundred largest filers — a moderate concentration level indicating that no single player has locked up the field, and meaningful positions remain open for challengers across several application verticals.
| # | Applicant | Patent families | Share |
|---|---|---|---|
| 1 | Cilag GmbH International | 293 | |
| 2 | Ventana Medical Systems Inc. | 191 | |
| 3 | IMEC vzw | 146 | |
| 4 | Viavi Solutions Inc. | 121 | |
| 5 | ChemImage Corporation | 115 | |
| 6 | Panasonic Intellectual Property Management Co., Ltd. | 114 | |
| 7 | Koninklijke Philips N.V. | 112 | |
| 8 | Samsung Electronics Co., Ltd. | 108 | |
| 9 | DEERE & CO | 103 | |
| 10 | Raytheon Company | 98 |
| # | Applicant | Patent families | Share |
|---|---|---|---|
| 11 | HyperMed Imaging Inc. | 88 | |
| 12 | The Boeing Company | 85 | |
| 13 | Corning Incorporated | 81 | |
| 14 | Ethicon Inc. | 78 | |
| 15 | XIAN INST OF OPTICS & PRECISION MECHANICS CHINESE … | 68 | |
| 16 | VTT Technical Research Centre of Finland | 56 | |
| 17 | Shanghai Institute of Technical Physics, Chinese Academy of Sciences | 56 | |
| 18 | Verily Life Sciences LLC | 56 | |
| 19 | Canon Inc. | 55 | |
| 20 | Omni MedSci Inc. | 54 |
The leaders’ positions reflect deep investment in surgical and diagnostic imaging (Cilag, Ventana, Ethicon), optical hardware and sensor design (IMEC, Viavi, ChemImage), and defense/aerospace sensing (Raytheon, Boeing), suggesting that competitive entry requires differentiation in at least one of these three vectors.
Patent publication typically lags filing by 18–24 months, so figures for 2024–2026 understate actual activity; trend reads for those years should be treated as provisional. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
Activity peaked in 2020 and has since plateaued; radiation measurement and image processing dominate the technology mix
The annual filing trend and IPC technology composition together reveal a field that has moved past its steepest growth phase into a broad, multi-vertical plateau, with a few high-density branches absorbing most filings and a long tail of lower-density adjacent classes.
Annual filing trend
Filings climbed sharply from 668 in 2017 to a peak of 1,078 in 2020, then settled into a range of roughly 928–969 through 2021–2023. Figures for 2024–2026 are suppressed by publication lag and should not be read as a real decline.
↗ Hover for values · click a bar to ask EurekaTechnology composition
G01J (Radiation & light measurement) and G06T (Image data processing) are the two largest branches, reflecting the dual hardware-software nature of hyperspectral systems. G01N (Material analysis), H04N (Pictorial communication), and A61B (Diagnosis & surgery) form a secondary tier, confirming that medical and analytical chemistry applications drive a substantial share of activity.
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
Hyperspectral sensor, hyperspectral imaging system…
Provided are a hyperspectral sensor including a window, a first focusing part provided on a rear surface of the window and including a plurality of lenses, a first image sensor provided on a rear surface of the first focusing part and having a front surface parallel to the rear surface of the window, a first mirror spaced apart from the first focusing part… (excerpt from the patent abstract)
| # | Patent | Citations |
|---|---|---|
| 1 | Methods for differential image quality enhancement… | 1,007 |
| 2 | Analytic methods of tissue evaluation | 797 |
| 3 | Capturing and processing of images using monolithi… | 719 |
| 4 | Method and system for providing recommendation for… | 664 |
| 5 | Systems and methods for the multispectral imaging … | 627 |
| 6 | Capturing and processing of images using monolithi… | 607 |
| 7 | Apparatus for multiple camera devices and method o… | 600 |
| 8 | Systems and methods for the multispectral imaging … | 578 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents. Some patent titles may be shown in their original, non-English language where an accurate translation could not be guaranteed.
What the competitive structure means for R&D investment decisions
The combination of mature lifecycle stage, moderate concentration, active academic-industry collaboration, and US-centric jurisdiction coverage defines both the entry barriers and the accessible gaps for new players.
Field is at maturity: annual volume has plateaued near the 2020 peak
The lifecycle stage is Maturity, with annual filings having plateaued near their 2020 peak of 1,078. Growth on the most recent multi-year window is slightly negative at -8%, consistent with a field transitioning from volume-driven expansion to quality-driven consolidation. R&D investment should target differentiated application niches rather than broad platform claims that incumbents already cover densely.
Lifecycle: MatureModerate concentration leaves room for focused challengers
With the top five filers accounting for 19% of the hundred largest filers’ combined output, the field is moderately concentrated but not foreclosed. The tier gap between the leader (Cilag, 293 patent families) and the fifth-ranked player (ChemImage, 115 patent families) is significant, yet the long tail of mid-tier filers — including Samsung, Deere, and Raytheon — indicates that multiple competitive postures remain viable. Challengers with narrow application focus can carve defensible positions.
Concentration: ModerateVentana Medical Systems anchors the most active co-filing network
The strongest co-applicant relationship in the corpus is Ventana Medical Systems paired with F. Hoffmann-La Roche, with 27 joint patent families, followed by Ventana with Oregon Health & Science University at 17. IMEC maintains its own cluster with KU Leuven at 11 joint families and KU Leuven R&D at 7. These links indicate that academic-industry partnerships are strategically important in the medical-imaging and photonics-hardware segments, and that unpartnered entrants may find it harder to compete in those sub-domains.
Ecosystem: Partnership-drivenUS-centric coverage with meaningful European and Chinese secondary presence
The United States accounts for the largest share of patent records, with Europe (EPO) and China forming a substantial secondary tier, and WIPO (PCT) filings indicating appetite for broad international protection. Germany, India, Canada, and Australia constitute a third tier. The relative underrepresentation of Japan and South Korea — despite Samsung and Panasonic ranking in the top ten — suggests those players may be concentrating their prosecution budgets in Western markets.
Geography: US-ledGo beyond the landscape: Eureka’s TRIZ Solution agent breaks down an R&D problem and returns patented concept solutions, each with a technical approach and cited patent & literature evidence.
| Applicant | Collaborator | Co-filings |
|---|---|---|
| Ventana Medical Systems Inc. | F. Hoffmann-La Roche Ltd. | 27 |
| Ventana Medical Systems Inc. | Oregon Health & Science University | 17 |
| IMEC (Interuniversitair Micro-Electronics Centrum vzw) | KU Leuven (Katholieke Universiteit Leuven) | 11 |
| IMEC (Interuniversitair Micro-Electronics Centrum vzw) | KU Leuven R&D | 7 |
| Ventana Medical Systems Inc. | F. Hoffmann-La Roche AG | 4 |
| Ventana Medical Systems Inc. | Mayo Foundation for Medical Education and Research | 3 |
| Ventana Medical Systems Inc. | Memorial Sloan Kettering Cancer Center | 2 |
| Ventana Medical Systems Inc. | Johns Hopkins University | 2 |
| IMEC (Interuniversitair Micro-Electronics Centrum vzw) | Ghent University | 1 |
Co-filing pairs, ranked by the number of jointly-filed patent families.
Cilag and Ventana lead on medtech imaging; IMEC anchors the photonics-hardware route
The top two players are both medtech-aligned, while IMEC represents a distinct hardware-sensor route; momentum diverges sharply across the top tier, with Cilag accelerating and Ventana declining.
Cilag GmbH International
Cilag leads with 293 patent families, concentrated in surgical and diagnostic imaging (A61B), image data processing (G06T), and radiation measurement (G01J). Recent momentum is positive at +25%, suggesting active continued investment rather than a harvesting posture. The portfolio breadth across both hardware sensing and clinical image analysis makes Cilag the most defensively positioned player in the corpus.
families: 293IMEC
IMEC ranks third with 146 patent families, with its technical emphasis concentrated in radiation and light measurement (G01J 3) and pictorial communication sensor design (H04N 25, H04N 23) — a distinct hardware-first route compared to the software-heavy approaches of the medtech leaders. Recent momentum shows a –26% decline, consistent with the broader plateau in the field, and IMEC’s strong co-filing relationship with KU Leuven (11 joint families) underscores its academic-partnership model.
families: 146| Applicant | Recent (3 yrs) | Trend |
|---|---|---|
| Ventana Medical Systems Inc. | 36 | ▼ -41% |
| IMEC (Interuniversitair Micro-Electronics Centrum vzw) | 14 | ▼ -26% |
| Cilag GmbH International | 79 | ▲ +25% |
| ChemImage Corporation | 1 | ▼ -94% |
| Rebellion Photonics Inc. | 29 | ▬ 0% |
| Viavi Solutions Inc. | 41 | ▬ +5% |
| Panasonic Intellectual Property Management Co., Ltd. | 53 | ▲ +23% |
| Koninklijke Philips N.V. | 39 | ▼ -11% |
Under-served branches adjacent to the dominant hyperspectral imaging core
Several IPC classes sit at meaningfully lower density relative to the dominant branches, and two stand out as technically adjacent with plausible entry paths for teams already active in hyperspectral sensing or image analytics.
G06N · Computing based on AI models
With a lower relative share compared to the dominant G01J and G06T branches, AI-model computing applied to hyperspectral data interpretation remains an under-served branch. Given that hyperspectral cubes are high-dimensional and analytically demanding, AI-driven spectral unmixing, anomaly detection, and classification represent a technically credible extension. Entry is accessible for players already holding G06T image-processing assets who can layer machine-learning claim sets on top of existing sensor pipelines.
Search this in Eureka →B64U · Unmanned aerial vehicles (drones)
Drone-borne hyperspectral platforms sit at a comparatively low filing density relative to the field’s core sensing and processing branches, despite clear demand in precision agriculture, environmental monitoring, and infrastructure inspection. The technical combination of miniaturized hyperspectral sensors (G01J) with drone navigation and payload integration (B64U) is feasible with current hardware, and the sparse filing record suggests that claim space in airborne deployment architectures, onboard processing, and geo-registration pipelines has not been heavily occupied by the current top tier.
Search this in Eureka →How leaders differ by technology route: sensing hardware vs. clinical image processing vs. material analysis
Strength of each leader across the main technology routes.
| Player | G01J 3 · Radiation & light measurement | G06T 7 · Image data processing & generation | G01N 21 · Material analysis & testing | H04N 23 · Pictorial communication (video/TV) | G06V 10 · Image/video recognition |
|---|---|---|---|---|---|
| Ethicon Inc. | Strong · 88 | Strong · 139 | Moderate · 54 | Strong · 74 | Absent |
| Rebellion Photonics Inc. | Strong · 120 | Absent | Strong · 100 | Emerging · 24 | Emerging · 16 |
| ChemImage Corporation | Strong · 128 | Absent | Strong · 76 | Absent | Absent |
| Ventana Medical Systems Inc. | Absent | Strong · 161 | Absent | Absent | Moderate · 33 |
| Cilag GmbH International | Absent | Strong · 104 | Absent | Strong · 56 | Absent |
| Panasonic Intellectual Property Management Co., Ltd. | Strong · 91 | Absent | Absent | Strong · 54 | Absent |
| Viavi Solutions Inc. | Strong · 106 | Absent | Moderate · 30 | Absent | Absent |
Frequently asked questions
The corpus in scope contains 7,707 patent families spanning the full hyperspectral imaging technology space across all major jurisdictions.
Cilag GmbH International leads with 293 patent families, ahead of Ventana Medical Systems (191) and IMEC (146). Cilag’s portfolio is concentrated in surgical imaging, image data processing, and radiation measurement.
The field is at a Maturity stage. Annual filings peaked at 1,078 in 2020 and have since plateaued in the 928–969 range. The most recent multi-year growth window is slightly negative at -8%. Figures for 2024–2026 are affected by publication lag and are not indicative of a real decline.
The United States leads by a wide margin, followed by Europe (EPO) and China as a secondary tier, with WIPO PCT filings indicating demand for broad international coverage. Germany, India, Canada, and Australia form a third tier.
G01J (Radiation & light measurement) and G06T (Image data processing & generation) are the two largest branches, reflecting the dual hardware-software architecture of hyperspectral systems. G01N (Material analysis), H04N (Pictorial communication), and A61B (Diagnosis & surgery) form a significant secondary tier.
Ventana Medical Systems and F. Hoffmann-La Roche have the most active co-applicant relationship with 27 joint patent families. Ventana also co-files with Oregon Health & Science University (17 families) and Mayo Foundation for Medical Education and Research (3 families). IMEC co-files with KU Leuven (11 families) and KU Leuven R&D (7 families).
Ready to map your own hyperspectral imaging landscape?
Join 18,000+ innovators using PatSnap Eureka to map any technology landscape: search 2B+ patents and papers, surface key assignees, and generate a report like this in minutes.
Disclaimer. This page is generated from PatSnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. PatSnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.